About
Catheter Ablation System for Heart Failure
Areas of Focus
Categories
Uncategorized Medical DeviceBiotech
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
318
By Phase
NA: 3PHASE1: 1
By Status
UNKNOWN: 2ENROLLING_BY_INVITATION: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04592445Lead Sponsor
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
NAUnknown
80 participants
Started: Dec 18, 2020 · Completed: Mar 31, 2023
NCT04287946Lead Sponsor
Endovascular GSN Ablation in Subjects With HFpEF
NAEnrolling by invitation
30 participants
Started: Feb 1, 2020 · Completed: Nov 30, 2024
NCT03229785Lead Sponsor
Quality of Life Improvements With Cord Blood Plasma
PHASE1Unknown
200 participants
Started: Apr 1, 2018 · Completed: Aug 1, 2019
NCT03715543Collaborator
Surgical Resection of the Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction
NACompleted
8 participants
Started: Aug 1, 2016 · Completed: Jun 30, 2019
Locations (1)
Headquarters
Santa Clara, CA, United States
Map
Loading map...